Literature DB >> 15191797

Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice.

Karin Borges1, Dayna L McDermott, Raymond Dingledine.   

Abstract

Mossy fiber sprouting (MFS), a common feature of human temporal lobe epilepsy and many epilepsy animal models, contributes to hippocampal hyperexcitability. The molecular events responsible for MFS are not well understood, although the growth-associated protein GAP-43 has been implicated in rats. Here, we focus on the hyaluronan receptor CD44, which is involved in routing of retinal axons during development and is upregulated after injury in many tissues including brain. After pilocarpine-induced status epilepticus (SE) in mice most hilar neurons died and neuropeptide Y (NPY) immunoreactivity appeared in the dentate inner molecular layer (IML) after 10-31 days indicative of MFS. Strong CD44 immunoreactivity appeared in the IML 3 days after pilocarpine, then declined over the next 4 weeks. Conversely, GAP-43 immunoreactivity was decreased in the IML at 3-10 days after pilocarpine-induced SE. After SE induced by repeated kainate injections, mice did not show any hilar cell loss or changes in CD44 or GAP-43 expression in the IML, and MFS was absent at 20-35 days. Thus, after SE in mice, early loss of GAP-43 and strong CD44 induction in the IML correlated with hilar cell loss and subsequent MFS. CD44 is one of the earliest proteins upregulated in the IML and coincides with early sprouting of mossy fibers, although its function is still unknown. We hypothesize that CD44 is involved in the response to axon terminal degeneration and/or neuronal reorganization preceding MFS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191797     DOI: 10.1016/j.expneurol.2004.03.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  16 in total

1.  Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus.

Authors:  Karin Borges; Dayna McDermott; Hasan Irier; Yoland Smith; Raymond Dingledine
Journal:  Exp Neurol       Date:  2006-06-21       Impact factor: 5.330

2.  Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43.

Authors:  John B Denny
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

3.  Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.

Authors:  G E Serrano; N Lelutiu; A Rojas; S Cochi; R Shaw; C D Makinson; D Wang; G A FitzGerald; R Dingledine
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

4.  Persistent decrease in multiple components of the perineuronal net following status epilepticus.

Authors:  Paulette A McRae; Esther Baranov; Stephanie L Rogers; Brenda E Porter
Journal:  Eur J Neurosci       Date:  2012-08-31       Impact factor: 3.386

5.  Senescence-accelerated Mice (SAMs) as a Model for Brain Aging and Immunosenescence.

Authors:  Atsuyoshi Shimada; Sanae Hasegawa-Ishii
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

Review 6.  Frontier of epilepsy research - mTOR signaling pathway.

Authors:  Chang Hoon Cho
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

7.  Reduction in delayed mortality and subtle improvement in retrograde memory performance in pilocarpine-treated mice with conditional neuronal deletion of cyclooxygenase-2 gene.

Authors:  Jamie R Levin; Geidy Serrano; Raymond Dingledine
Journal:  Epilepsia       Date:  2012-07-10       Impact factor: 5.864

8.  Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models.

Authors:  Sarah Willis; James Stoll; Lawrence Sweetman; Karin Borges
Journal:  Neurobiol Dis       Date:  2010-08-04       Impact factor: 5.996

9.  Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus.

Authors:  Nicholas H Varvel; Jonas J Neher; Andrea Bosch; Wenyi Wang; Richard M Ransohoff; Richard J Miller; Raymond Dingledine
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

10.  Characterization of osteopontin expression and function after status epilepticus.

Authors:  Karin Borges; Marla Gearing; Susan Rittling; Esben S Sorensen; Robert Kotloski; David T Denhardt; Raymond Dingledine
Journal:  Epilepsia       Date:  2008-06-03       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.